Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 12, 2009
Anti-IL-10R antibody improves the therapeutic efficacy of targeted liposomal oligonucleotides
Chiara Brignole, Danilo Marimpietri, Fabio Pastorino, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 25, 2013
Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma
Daniela Di Paolo, Fabio Pastorino, Guendalina Zuccari, et al.
Cancer Research
|
October 12, 2010
Therapeutic targeting of TLR9 inhibits cell growth and induces apoptosis in neuroblastoma
Chiara Brignole, Danilo Marimpietri, Daniela Di Paolo, et al.
Methods in Enzymology
|
November 17, 2009
Liposome-mediated therapy of neuroblastoma
Daniela Di Paolo, Monica Loi, Fabio Pastorino, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 14, 2011
Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK
Daniela Di Paolo, Chiara Brignole, Fabio Pastorino, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 11, 2011
Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma
Daniela Di Paolo, Chiara Ambrogio, Fabio Pastorino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response
Gabriella Pagnan, Daniela Di Paolo, Roberta Carosio, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 3, 2015
Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma
Guendalina Zuccari, Andrea Milelli, Fabio Pastorino, et al.
Cell Reports
|
April 28, 2016
Macroautophagy Proteins Control MHC Class I Levels on Dendritic Cells and Shape Anti-viral CD8(+) T Cell Responses
Monica Loi, Anne Müller, Karin Steinbach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2008
Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin
Fabio Pastorino, Daniela Di Paolo, Federica Piccardi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 12, 2009
Anti-IL-10R antibody improves the therapeutic efficacy of targeted liposomal oligonucleotides
Chiara Brignole, Danilo Marimpietri, Fabio Pastorino, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 25, 2013
Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma
Daniela Di Paolo, Fabio Pastorino, Guendalina Zuccari, et al.
Cancer Research
|
October 12, 2010
Therapeutic targeting of TLR9 inhibits cell growth and induces apoptosis in neuroblastoma
Chiara Brignole, Danilo Marimpietri, Daniela Di Paolo, et al.
Methods in Enzymology
|
November 17, 2009
Liposome-mediated therapy of neuroblastoma
Daniela Di Paolo, Monica Loi, Fabio Pastorino, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 14, 2011
Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK
Daniela Di Paolo, Chiara Brignole, Fabio Pastorino, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 11, 2011
Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma
Daniela Di Paolo, Chiara Ambrogio, Fabio Pastorino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 21, 2009
The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response
Gabriella Pagnan, Daniela Di Paolo, Roberta Carosio, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
June 3, 2015
Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma
Guendalina Zuccari, Andrea Milelli, Fabio Pastorino, et al.
Cell Reports
|
April 28, 2016
Macroautophagy Proteins Control MHC Class I Levels on Dendritic Cells and Shape Anti-viral CD8(+) T Cell Responses
Monica Loi, Anne Müller, Karin Steinbach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2008
Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin
Fabio Pastorino, Daniela Di Paolo, Federica Piccardi, et al.
Page
of 3